Founder Advisory
Building a Credible Healthcare Business From Research IP
A founder's account of taking a university research tool into some of the hardest-to-enter institutions in healthcare — bootstrapped, without venture funding.
The Opening
It began as a major university's radiation oncology project: software to reduce errors during cancer treatment — a serious patient-safety problem, arriving just as new treatment-quality standards were spreading to providers. The opening was real. But a good idea and good timing are not a business.
The Real Problem
A validated problem is not a validated business. The proof mattered; the product no one would adopt did not. It was standalone research software — it didn't connect to the systems providers already used, and it asked busy institutions to run something separate. And I was entering a closed market with no name, no track record, no relationships. Selling harder would fix neither the access problem nor the adoption one.
Founders reach for a solution — "I need sales," "I need marketing." The more useful move is to find the real problem before acting on the stated one.The Build
So the product came first. I had the research tool rebuilt to fit inside the provider's world, outsourcing much of the work on debt. With no brand of my own, I borrowed credibility: the university got the finished product free for its own use, the company kept commercial rights on a revenue share, and key stakeholders came in with a stake and opened doors a cold approach never could. The first customer was a federal unit — one of the hardest to win, and exactly why it became the proof everything rested on. The product ran free for six months to build real usage, then moved to paid on what people relied on, with services as a second, repeating income line. A later ONC federal innovation award didn't start the company — its funding kept a bootstrapped one alive. And because the mission paid what money couldn't, a team formed with no payroll — on recognition, co-authorship, and a stake.
The Step Most Ventures Never Reach
The last piece was removing my own dependency. Deployment, qualification, onboarding, and support were written into a playbook; relationships were handed to the team and to champions inside each account. A business only becomes transferable when the work lives in the organisation, not in one head — which is why the handover to the new CEO closed cleanly, with no customers lost.
What It Added Up To
- A demonstrated 15% reduction in treatment errors — proof it worked, not just that it sold
- Three real customers from a standing start: a federal healthcare unit (the anchor), a leading academic medical university, and a UK provider
- 1 → 3 paying institutions within 12 months; ARR $50K → $90K
- Handed to a new CEO in a self-running state — 4-month transition, zero customer loss
The Takeaways I Give Founders — Because I Lived Them
"A validated problem is not a validated business."
"In a closed market, an outsider's first job isn't selling — it's finding a credible way in. Borrow it if you can't build it yet."
"When adoption stalls, look at the product before you blame the pitch."
"If the only way to your next customer runs through you, that's founder-market fit, not product-market fit."
"Before you can pay people, the mission is your payroll — and commercial maturity isn't revenue, it's repeatability."
Kept short on purpose. The longer version holds the harder part — the tensions, the trade-offs, and what fought back. Where it maps to something you're facing, I'll share the full account or walk you through it.